+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Cough and Cold Preparations Global Market Report 2021: COVID-19 Implications and Growth to 2030

  • ID: 5319119
  • Report
  • April 2021
  • Region: Global
  • The Business Research Company

FEATURED COMPANIES

  • Aaron Industries Inc.
  • Aurobindo Pharma Ltd
  • Blackmores Limited
  • GlaxoSmithKline
  • Novartis
  • Procter & Gamble
Cough And Cold Preparations Global Market Report 2021: COVID-19 Implications And Growth to 2030 covers this critical market and the impact on it from the COVID-19 virus. It provides strategists, marketers and senior management with the critical information they need to assess the increasing demand for cough and cold preparations due to COVID-19.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is experiencing rapid growth due to the coronavirus and how it is likely to stabilize as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Description:

Where is the largest and fastest growing market for the cough and cold preparations? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Cough And Cold Preparations Market Global Report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The Market Characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:
1) By Drug Type: Antihistamines; Expectorants; Bronchodilators; Decongestants; Antibiotics; Others
2) By Dosage Type: Oral Syrups; Tablets/Pills; Nasal Drops; Lozenges; Others
3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Drug Stores

Companies Mentioned: AstraZeneca; Bayer; Blackmores Limited; Dabur; GlaxoSmithKline

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast.

Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.


This product will be delivered within 1-3 business days.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Aaron Industries Inc.
  • Aurobindo Pharma Ltd
  • Blackmores Limited
  • GlaxoSmithKline
  • Novartis
  • Procter & Gamble

1. Executive Summary2. Cough And Cold Preparations Market Characteristics3. Cough And Cold Preparations Market Trends And Strategies4. Impact Of COVID-19 on Cough And Cold Preparations
5. Cough And Cold Preparations Market Size And Growth
5.1. Global Cough And Cold Preparations Historic Market, 2015-2020, $ Billion
5.1.1. Drivers of the Market
5.1.2. Restraints on The Market
5.2. Global Cough And Cold Preparations Forecast Market, 2020-2025F, 2030F, $ Billion
5.2.1. Drivers of the Market
5.2.2. Restraints on the Market
6. Cough And Cold Preparations Market Segmentation
6.1. Global Cough And Cold Preparations Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Antihistamines
  • Expectorants
  • Bronchodilators
  • Decongestants
  • Antibiotics
  • Others
6.2. Global Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Oral Syrups
  • Tablets/Pills
  • Nasal Drops
  • Lozenges
  • Others
6.3. Global Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug Stores

7. Cough And Cold Preparations Market Regional And Country Analysis
7.1. Global Cough And Cold Preparations Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
7.2. Global Cough And Cold Preparations Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
8. Asia-Pacific Cough And Cold Preparations Market
8.1. Asia-Pacific Cough And Cold Preparations Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Cough And Cold Preparations Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
8.3. Asia-Pacific Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
8.4. Asia-Pacific Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
9. China Cough And Cold Preparations Market
9.1. China Cough And Cold Preparations Market Overview
9.2. China Cough And Cold Preparations Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion
9.3. China Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion
9.4. China Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion
10. India Cough And Cold Preparations Market
10.1. India Cough And Cold Preparations Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
10.2. India Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
10.3. India Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
11. Japan Cough And Cold Preparations Market
11.1. Japan Cough And Cold Preparations Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
11.2. Japan Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
11.3. Japan Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
12. Australia Cough And Cold Preparations Market
12.1. Australia Cough And Cold Preparations Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
12.2. Australia Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
12.3. Australia Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
13. Indonesia Cough And Cold Preparations Market
13.1. Indonesia Cough And Cold Preparations Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
13.2. Indonesia Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
13.3. Indonesia Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
14. South Korea Cough And Cold Preparations Market
14.1. South Korea Cough And Cold Preparations Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
14.2. South Korea Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
14.3. South Korea Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
15. Western Europe Cough And Cold Preparations Market
15.1. Western Europe Cough And Cold Preparations Market Overview
15.2. Western Europe Cough And Cold Preparations Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
15.3. Western Europe Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
15.4. Western Europe Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
16. UK Cough And Cold Preparations Market
16.1. UK Cough And Cold Preparations Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
16.2. UK Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
16.3. UK Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
17. Germany Cough And Cold Preparations Market
17.1. Germany Cough And Cold Preparations Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
17.2. Germany Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
17.3. Germany Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
18. France Cough And Cold Preparations Market
18.5. France Cough And Cold Preparations Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
18.6. France Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
18.7. France Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
19. Eastern Europe Cough And Cold Preparations Market
19.1. Eastern Europe Cough And Cold Preparations Market Overview
19.2. Eastern Europe Cough And Cold Preparations Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
19.3. Eastern Europe Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
19.4. Eastern Europe Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
20. Russia Cough And Cold Preparations Market
20.1. Russia Cough And Cold Preparations Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
20.2. Russia Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
20.3. Russia Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
21. North America Cough And Cold Preparations Market
21.1. North America Cough And Cold Preparations Market Overview
21.2. North America Cough And Cold Preparations Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
21.3. North America Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
21.4. North America Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
22. USA Cough And Cold Preparations Market
22.1. USA Cough And Cold Preparations Market Overview
22.2. USA Cough And Cold Preparations Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
22.3. USA Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
22.4. USA Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
23. South America Cough And Cold Preparations Market
23.1. South America Cough And Cold Preparations Market Overview
23.2. South America Cough And Cold Preparations Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
23.3. South America Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
23.4. South America Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
24. Brazil Cough And Cold Preparations Market
24.1. Brazil Cough And Cold Preparations Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
24.2. Brazil Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
24.3. Brazil Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
25. Middle East Cough And Cold Preparations Market
25.1. Middle East Cough And Cold Preparations Market Overview
25.2. Middle East Cough And Cold Preparations Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
25.3. Middle East Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
25.4. Middle East Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
26. Africa Cough And Cold Preparations Market
26.1. Africa Cough And Cold Preparations Market Overview
26.2. Africa Cough And Cold Preparations Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
26.3. Africa Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
26.4. Africa Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
27. Cough And Cold Preparations Market Competitive Landscape And Company Profiles
27.1. Cough And Cold Preparations Market Competitive Landscape
27.2. Cough And Cold Preparations Market Company Profiles
27.2.1. AstraZeneca
27.2.1.1. Overview
27.2.1.2. Products and Services
27.2.1.3. Strategy
27.2.1.4. Financial Performance
27.2.2. Bayer
27.2.2.1. Overview
27.2.2.2. Products and Services
27.2.2.3. Strategy
27.2.2.4. Financial Performance
27.2.3. Blackmores Limited
27.2.3.1. Overview
27.2.3.2. Products and Services
27.2.3.3. Strategy
27.2.3.4. Financial Performance
27.2.4. Dabur
27.2.4.1. Overview
27.2.4.2. Products and Services
27.2.4.3. Strategy
27.2.4.4. Financial Performance
27.2.5. GlaxoSmithKline
27.2.5.1. Overview
27.2.5.2. Products and Services
27.2.5.3. Strategy
27.2.5.4. Financial Performance
28. Cough And Cold Preparations Pipeline Analysis29. Key Mergers And Acquisitions In The Cough And Cold Preparations Market30. Cough And Cold Preparations Market Future Outlook and Potential Analysis
31. Appendix
31.1. Abbreviations
31.2. Currencies
31.3. Research Inquiries
31.4. About the Publisher
31.5. Copyright And Disclaimer
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Aaron Industries Inc.
  • Aurobindo Pharma Ltd
  • Blackmores Limited
  • GlaxoSmithKline
  • Novartis
  • Procter & Gamble
Major players in the cold and cough preparations market are AstraZeneca, Bayer, Blackmores Limited, Dabur, and GlaxoSmithKline.

The global cough and cold preparations market is expected to decline from $14.94 billion in 2020 to $13.02 billion in 2021 at a compound annual growth rate (CAGR) of -12.9%. The change in growth trend is mainly due to the companies stabilizing their output after catering to the demand that grew exponentially during the COVID-19 pandemic in 2020. The market is expected to reach $12.37 billion in 2025 at a CAGR of -1.3%.

The cold and cough preparations market consists of sales of drugs for cold and cough. The drugs for the treatment of cold and cough acts on the receptors to which the virus causing the infection gets attached to, by antagonizing the action of the receptors and killing the viral infection, thereby reducing congestion by lysing the mucus and dilating the bronchioles constricted by the mucus deposition. In this market, sales of antihistamines, antibiotics, decongestants, expectorants and bronchodilators are also included.

The cold and cough preparations market is regulated by authorities such as the Food and Drug Administration in the US. For instance, in November 2018, the Food and Drug Administration (FDA) restricted the use of codeine in children. Codeine is approved to treat pain and cough but this medicine carries serious risks, including slowed or difficult breathing and can be potentially fatal. This risk is greater in children younger than 12 years but the use of codeine should also be limited in some older children. Single-ingredient codeine is FDA-approved only for use in adults. FDA is also recommending against the use of codeine in breastfeeding mothers due to possible harm to their infants.

Threat from substitute products such as generic and counterfeit drugs, is significantly restraining the global cold and cough preparations market. Pharmaceutical companies invest a large sum of money in drug development process. Once a drug candidate is developed and approved by the regulatory authorities, companies patent their inventions to protect their intellectual property. During the patency period, the company holding the patent holds exclusivity for manufacturing and distribution. Post expiration of patency, generic versions of the drugs are manufactured by other companies. The prices of the generics are very low in comparison to the original brand of the drug. According to an article of Alpha Invesco, a new FDA-approved blockbuster drug that netted $100 million a year in profit during its patent protection duration could become one that earns only $1 million a year in profit overnight after losing its patent. Additionally, there is a major international problem with counterfeit drugs. The best of these counterfeits duplicates a real drug’s formula and sells it at a lower price, which hurts pharmaceutical companies' profits. Moreover, the counterfeits made with low-grade materials can destroy the reputations of the legitimate products, thus affecting the growth of the market.

Advancements in technologies are driving the global pharmaceutical sector including cold and cough preparations. According to global life sciences report by Deloitte, adoption of AI, robotic automation, the Internet of Medical Things (IoMT), blockchain, DIY diagnostics, virtual care, mobility in drug delivery and clinical trials, genomics, next-generation therapies, cloud computing, Real-World Evidence (RWE), and data-driven precision medicine are the major technologies driving the life sciences sector. AI technology is being used in diagnoses, treatment planning, patient monitoring, and drug discovery. The IoMT is allowing new business models to emerge and enhancing customer experiences. Pharmaceutical companies are also increasingly using biomarkers in the drug development process to reduce the time taken to bring the product into the market. Biomarkers are biological indicators which are objectively measured and evaluated for biological processes, pathogenic processes or pharmacological responses to a therapeutic intervention.
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • AstraZeneca
  • Bayer
  • Blackmores Limited
  • Dabur
  • GlaxoSmithKline
  • Himalaya Global Holdings
  • Hyland's
  • Johnson & Johnson
  • Novartis
  • Perrigo Company
  • Pfizer
  • Prestige Brands
  • Procter & Gamble
  • Reckitt Benckiser
  • Sun Pharmaceutical Industries
  • Taro Pharmaceutical Industries Ltd
  • Tris Pharma Inc
  • Tsumura & Co
  • Aaron Industries Inc.
  • AccuMed Inc.
  • Acella Pharmaceuticals LLC
  • Amneal Pharmaceuticals LLC
  • Atley Pharmaceuticals
  • Aurobindo Pharma Ltd
  • Aytu BioScience Inc.
  • Biozone Laboratories Inc.
  • Boiron Group
  • Charleston Laboratories Inc
  • Emami Ltd. (Zandu Pharmaceutical Works Ltd)
  • Exscientia Ltd
Note: Product cover images may vary from those shown

Loading
LOADING...